Biotechnology - Salt Lake City, Utah, United States
Using mature evolutionary algorithms, we design and validate de novo peptides, aptamers, and macrocycles to modify protein-protein interactions. De novo design enables us to quickly and cheaply output fewer, more precisely configured candidates for drug discovery and diagnostics than current industry practices allow. We also offer high-throughput surface plasmon resonance (SPR) and peptide synthesis to enable clients to quickly and cheaply screen massive amounts of antibodies and other protein-protein interactions. We offer end to end discovery to the manufacturing of proteins at scale.
Squarespace ECommerce
NSOne
Typekit
Mobile Friendly